Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke S Howard

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
Rheumatology (Oxford, England)|October 25, 2013
Iron deficiency in systemic sclerosis patients with and without pulmonary hypertensionGerrina Ruiter, Irene J Lanser, Frances S de Man, et al.
BMJ Open Respiratory Research|July 25, 2023
Right ventricular functional recovery assessment with stress echocardiography and cardiopulmonary exercise testing after pulmonary embolism: a pilot prospective multicentre studyChinthaka Bhagya Samaranayake, John Upham, Khoa Tran, et al.
American Journal of Respiratory and Critical Care Medicine|May 9, 2025
Clustering Pulmonary Hypertension Patients Using the Plasma ProteomeAthénaïs Boucly, Shanshan Song, Merve Keles, et al.
The European Respiratory Journal|October 16, 2020
Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertensionEmilia M Swietlik, Pavandeep Ghataorhe, Kasia I Zalewska, et al.
Pulmonary Circulation|February 19, 2026
Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER StudyLuke S Howard, David G Kiely, Allan Lawrie, et al.
Pulmonary Circulation|September 25, 2015
Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiencyGerrina Ruiter, Emmy Manders, Chris M Happé, et al.
The Lancet. Respiratory Medicine|September 19, 2017
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled studyHossein-Ardeschir Ghofrani, Gérald Simonneau, Andrea M D'Armini, et al.
The Lancet. Respiratory Medicine|March 28, 2024
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled studyHossein-Ardeschir Ghofrani, Gérald Simonneau, Andrea M D'Armini, et al.
BMJ Open Respiratory Research|June 30, 2018
British Thoracic Society Guideline for the initial outpatient management of pulmonary embolismLuke S Howard, Steven Barden, Robin Condliffe, et al.
ERJ Open Research|May 26, 2022
ERS International Congress 2021: highlights from the Pulmonary Vascular Diseases AssemblyMona Lichtblau, Lucilla Piccari, Sheila Ramjug, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Rheumatology (Oxford, England)|October 25, 2013
Iron deficiency in systemic sclerosis patients with and without pulmonary hypertensionGerrina Ruiter, Irene J Lanser, Frances S de Man, et al.
BMJ Open Respiratory Research|July 25, 2023
Right ventricular functional recovery assessment with stress echocardiography and cardiopulmonary exercise testing after pulmonary embolism: a pilot prospective multicentre studyChinthaka Bhagya Samaranayake, John Upham, Khoa Tran, et al.
American Journal of Respiratory and Critical Care Medicine|May 9, 2025
Clustering Pulmonary Hypertension Patients Using the Plasma ProteomeAthénaïs Boucly, Shanshan Song, Merve Keles, et al.
The European Respiratory Journal|October 16, 2020
Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertensionEmilia M Swietlik, Pavandeep Ghataorhe, Kasia I Zalewska, et al.
Pulmonary Circulation|February 19, 2026
Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER StudyLuke S Howard, David G Kiely, Allan Lawrie, et al.
Pulmonary Circulation|September 25, 2015
Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiencyGerrina Ruiter, Emmy Manders, Chris M Happé, et al.
The Lancet. Respiratory Medicine|September 19, 2017
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled studyHossein-Ardeschir Ghofrani, Gérald Simonneau, Andrea M D'Armini, et al.
The Lancet. Respiratory Medicine|March 28, 2024
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled studyHossein-Ardeschir Ghofrani, Gérald Simonneau, Andrea M D'Armini, et al.
BMJ Open Respiratory Research|June 30, 2018
British Thoracic Society Guideline for the initial outpatient management of pulmonary embolismLuke S Howard, Steven Barden, Robin Condliffe, et al.
ERJ Open Research|May 26, 2022
ERS International Congress 2021: highlights from the Pulmonary Vascular Diseases AssemblyMona Lichtblau, Lucilla Piccari, Sheila Ramjug, et al.
Pageof 12